Structural interventions to reduce HIV transmission among injecting drug users

被引:115
|
作者
Des Jarlais, DC [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Inst Chem Dependency, New York, NY 10003 USA
关键词
substance abuse; drug use; HIV; AIDS; prevention; structural intervention; policy;
D O I
10.1097/00002030-200006001-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To review current knowledge of 'structural' interventions to reduce HIV transmission among injecting drug users. Structural interventions are defined as programs or policies that change the environments in which risk behavior occurs, without attempting to change knowledge, attitudes or social interaction patterns of the persons at risk. Structural interventions may either facilitate enactment of existing motives to avoid HIV transmission or make enacting risk behavior more difficult. Methods: Nonquantitative literature review. Results and conclusions: Preventing HIV infection among injecting drug users must be considered within the context of the continuing global spread of psychoactive drug use, and injecting drug use in particular. Some policies that are designed to reduce drug use may tend to increase HIV transmission among persons who do inject drugs. Evaluation of-structural interventions can be difficult, as populations of drug users are usually the relevant unit of analysis. Typically, pre versus post comparisons must be used, hopefully with multiple pre and post data points. Structural interventions are often associated with 'large effects', increasing confidence that the intervention is the cause of the reduction in HIV-risk behavior. Increasing the availability of sterile injection equipment, through pharmacy sales or syringe exchange or both, is the most common and best-studied structural intervention for injecting drug users. The studies to date indicate that this usually, but not always, leads to large reductions in HIV-risk behavior. Involving drug users in the design and implementation of HIV-prevention programs can be considered a 'meta-structural' intervention that should lead to programs with increased effectiveness. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:S41 / S46
页数:6
相关论文
共 50 条
  • [31] High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia
    Iskandar, Shelly
    Basar, Diba
    Hidayat, Teddy
    Siregar, Ike M. P.
    Pinxten, Lucas
    van Crevel, Reinout
    Van der Ven, Andre J. A. M.
    De Jong, Cor A. J.
    BMC PUBLIC HEALTH, 2010, 10
  • [32] Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users
    Gibson, DR
    McCusker, J
    Chesney, M
    AIDS, 1998, 12 (08) : 919 - 929
  • [33] The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions
    Laura M. Kuyper
    Robert S. Hogg
    Julio S. G. Montaner
    Martin T. Schechter
    Evan Wood
    Journal of Urban Health, 2004, 81 : 655 - 660
  • [34] Can intranasal drug use reduce HCV infection among injecting drug users?
    Des Jarlais, Don C.
    Hagan, Holly
    Arasteh, Kamyar
    McKnight, Courtney
    Semaan, Salaam
    Perlman, David C.
    DRUG AND ALCOHOL DEPENDENCE, 2011, 119 (03) : 201 - 206
  • [35] The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions
    Kuyper, LM
    Hogg, RS
    Montaner, JSG
    Schechter, MT
    Wood, E
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2004, 81 (04): : 655 - 660
  • [36] Perceptions of HIV rapid testing among injecting drug users in Brazil
    Telles-Dias, P. R.
    Westman, S.
    Fernandez, A. E.
    Sanchez, M.
    REVISTA DE SAUDE PUBLICA, 2007, 41
  • [37] INTERNATIONAL EPIDEMIOLOGY OF HIV AND AIDS AMONG INJECTING DRUG-USERS
    DESJARLAIS, DC
    FRIEDMAN, SR
    CHOOPANYA, K
    VANICHSENI, S
    WARD, TP
    AIDS, 1992, 6 (10) : 1053 - 1068
  • [38] HIV RISK BEHAVIOR AMONG INJECTING DRUG-USERS IN WARSAW
    STARK, K
    SIEROSLAWSKI, J
    WIRTH, D
    GODWODSIKORSKA, C
    MULLER, R
    BIENZLE, U
    AIDS, 1995, 9 (02) : 211 - 213
  • [39] Maintaining low HIV seroprevalence among injecting drug users - Reply
    DesJarlais, DC
    Friedman, SR
    Hagan, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (08): : 597 - 598
  • [40] Estimating the size of the HIV epidemic among injecting drug users in Amsterdam
    vanHaastrecht, HJA
    Bindels, PJE
    vandenHoek, AAR
    Coutinho, RA
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1997, 13 (03) : 261 - 265